Lung Innate Immunity and Microbiome After Tuberculosis Exposure
NCT06526689 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2025-01-22
Summary
To characterise the innate pulmonary immune response and respiratory microbiome after recent exposure to M.tb and to evaluate how differences determine the outcome of M.tb exposure
Conditions
- Tuberculosis
- Latent Tuberculosis
Sponsors & Collaborators
-
University College, London
collaborator OTHER -
University of Oxford
lead OTHER
Principal Investigators
-
Helen McShane, PhD · University of Oxford
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-08-15
- Primary Completion
- 2026-10-01
- Completion
- 2028-10-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Immunological Biomarkers in Tuberculosis Management
NCT04271397 ·Status: RECRUITING ·Phase: NA
-
Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment
NCT06845618 ·Status: RECRUITING
-
Expression of Tuberculosis in the Lung
NCT00201253 ·Status: COMPLETED
-
Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis Infection
NCT02512939 ·Status: COMPLETED ·Phase: NA
-
Innovation in Tuberculosis
NCT04002869 ·Status: UNKNOWN
-
Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis
NCT04930978 ·Status: RECRUITING
-
Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
NCT04148053 ·Status: UNKNOWN
-
Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
NCT05571735 ·Status: RECRUITING
-
Prevalence and Clinical Significance of Co-infection of Mycoplasma Pneumoniae in Patients With Pulmonary Tuberculosis
NCT00926601 ·Status: UNKNOWN
-
Identifcation of Biomarkers for Active Pulmonary Tuberculosis
NCT04490746 ·Status: UNKNOWN
-
Respiratory Microbiota and Immune Response in CVID
NCT06173128 ·Status: COMPLETED
-
Immune Responses to Mycobacterium Tuberculosis (Mtb) in People With Latent Tuberculosis Infection With or Without Concomitant Helminth Infection
NCT02225158 ·Status: TERMINATED
-
Immune Response to Mycobacterium Tuberculosis Infection
NCT00257907 ·Status: COMPLETED
-
Improving the Diagnostic of Tuberculosis
NCT02861768 ·Status: COMPLETED ·Phase: NA
-
PRecision biomArker-Guided MAnagement of TuberculosIs Contacts: a Discrete Choice Experiment
NCT07024836 ·Status: RECRUITING
-
Diagnostic Utility of Mycobacterium Tuberculosis Cell-free DNA
NCT06439810 ·Status: RECRUITING
-
Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis
NCT06764576 ·Status: RECRUITING
-
Time-to-Detection in Culture of Mycobacterium Tuberculosis
NCT05568368 ·Status: COMPLETED
-
Immunocompetent Versus Immunocompromised Tuberculosis (TB) Patients
NCT06709157 ·Status: NOT_YET_RECRUITING
-
Serum Inflammatory Marker in Patients With Diagnosis of Nontuberculous Mycobacterial Pulmonary Infection
NCT00942916 ·Status: COMPLETED
-
Biomarkers for Therapy Response in Drug-resistant Tuberculosis
NCT02597621 ·Status: COMPLETED
-
Cytometric Immunodiagnostics of Latent Tuberculosis Infection (LTBI)
NCT04673227 ·Status: UNKNOWN
-
Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects
NCT01587469 ·Status: COMPLETED
-
Comorbidities and Coinfections in Latent TB
NCT04642755 ·Status: RECRUITING
-
Tuberculosis Immunity in Children
NCT00170638 ·Status: COMPLETED